Recombinant murine calreticulin fragment 39-272 expands CD1dhiCD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice

Molecular Immunology

Volumn 55, Issue 3-4, 2013, Pages 237-246

  Hong, Chao ^a   Zhang, Tengteng ^a   Gao, Xiao Ming ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Calreticulin; EAE; IL 10; RegulatoryB cells

Indexed keywords

CALRETICULIN; CD1D ANTIGEN; CD5 ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; PROTEIN ANTIBODY; RECOMBINANT CALRETICULIN[39-272]; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DISEASE SEVERITY; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; CALRETICULIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTOR 4;

ANIMALIA; MURINAE; MUS;

EID: 84877628884     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.02.003     Document Type: Article

References (37)

1. Arosa F.A., de Jesus O., Porto G., Carmo A.M., de Sousa M. Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. Journal of Biological Chemistry 1999, 274:16917-16922.
2. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. Journal of Biological Chemistry 2002, 277:15028-15034.
3. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. Journal of Experimental Medicine 1999, 190:995-1004.
4. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
5. Calderon-Gomez E., Lampropoulou V., Shen P., Neves P., Roch T., Stervbo U., Rutz S., Kuhl A.A., Heppner F.L., Loddenkemper C., et al. Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. European Journal of Immunology 2011, 41:1696-1708.
6. Carter N.A., Vasconcellos R., Rosser E.C., Tulone C., Munoz-Suano A., Kamanaka M., Ehrenstein M.R., Flavell R.A., Mauri C. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. Journal of Immunology 2011, 186:5569-5579.
7. Clarke C., Smyth M.J. Calreticulin exposure increases cancer immunogenicity. Nature Biotechnology 2007, 25:192-193.
8. Cohen-Sfady M., Nussbaum G., Pevsner-Fischer M., Mor F., Carmi P., Zanin-Zhorov A., Lider O., Cohen I.R. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. Journal of Immunology 2005, 175:3594-3602.
9. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. Journal of Immunology 2000, 165:4848-4853.
10. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nature Immunology 2002, 3:944-950.
11. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., Bratton D.L., Oldenborg P.A., Michalak M., Henson P.M. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123:321-334.
12. Hoehlig K., Shen P., Lampropoulou V., Roch T., Malissen B., O'Connor R., Ries S., Hilgenberg E., Anderton S.M., Fillatreau S. Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE. European Journal of Immunology 2012, 42:1164-1173.
13. Hong C., Qiu X., Li Y., Huang Q., Zhong Z., Zhang Y., Liu X., Sun L., Lv P., Gao X.M. Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease. Journal of Immunology 2010, 185:4561-4569.
14. Huang Q.Q., Sobkoviak R., Jockheck-Clark A.R., Shi B., Mandelin A.M.2nd, Tak P.P., Haines G.K.3rd, Nicchitta C.V., Pope R.M. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. Journal of Immunology 2009, 182:4965-4973.
15. Jorgensen C.S., Ryder L.R., Steino A., Hojrup P., Hansen J., Beyer N.H., Heegaard N.H., Houen G. Dimerization and oligomerization of the chaperone calreticulin. European Journal of Biochemistry 2003, 270:4140-4148.
16. Krause K.H., Michalak M. Calreticulin Cell 1997, 88:439-443.
17. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderon Gomez E., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. Journal of Immunology 2008, 180:4763-4773.
18. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nature Reviews Immunology 2010, 10:236-247.
19. Maseda D., Smith S.H., DiLillo D.J., Bryant J.M., Candando K.M., Weaver C.T., Tedder T.F. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. Journal of Immunology 2011, 188:1036-1048.
20. Matsushita T., Horikawa M., Iwata Y., Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. Journal of Immunology 2010, 185:2240-2252.
21. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. Journal of Clinical Investigation 2008, 118:3420-3430.
22. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochemical Journal 1999, 2(344 Pt):281-292.
23. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature Immunology 2009, 10:1178-1184.
24. O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., Barbis D., Stall A., Cupp J., Moore K., et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. International Immunology 1990, 2:821-832.
25. Olkhanud P.B., Damdinsuren B., Bodogai M., Gress R.E., Sen R., Wejksza K., Malchinkhuu E., Wersto R.P., Biragyn A. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Research 2011, 71:3505-3515.
26. Pawaria S., Binder R.J. CD91-dependent programming of T-helper cell responses following heat shock protein immunization. Nature Communication 2011, 2:521.
27. Pockley A.G. Heat shock proteins as regulators of the immune response. Lancet 2003, 362:469-476.
28. Qiu X., Hong C., Zhong Z., Li Y., Zhang T., Bao W., Xiong S., Gao X.M. Modulation of cellular immunity by antibodies against calreticulin. European Journal of Immunology 2012, 42:2419-2430.
29. Tarr J.M., Winyard P.G., Ryan B., Harries L.W., Haigh R., Viner N., Eggleton P. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells. Arthritis and Rheumatism 2010, 62:2919-2929.
30. Tedder T.F., Matsushita T. Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease. Journal of Allergy and Clinical Immunology 2010, 125:1125-1127.
31. Tian J., Zekzer D., Hanssen L., Lu Y., Olcott A., Kaufman D.L. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. Journal of Immunology 2001, 167:1081-1089.
32. Vassilakos A., Michalak M., Lehrman M.A., Williams D.B. Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin. Biochemistry 1998, 37:3480-3490.
33. Wallin R.P., Lundqvist A., More S.H., von Bonin A., Kiessling R., Ljunggren H.G. Heat-shock proteins as activators of the innate immune system. Trends in Immunology 2002, 23:130-135.
34. Wan T., Zhou X., Chen G., An H., Chen T., Zhang W., Liu S., Jiang Y., Yang F., Wu Y., et al. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 2004, 103:1747-1754.
35. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., Sato S., Tedder T.F., Fujimoto M. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. Journal of Immunology 2010, 184:4801-4809.
36. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
37. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. Journal of Immunology 2009, 182:7459-7472.